Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bradley John Dilkes Insider Profile
4 Followers
Bradley John Dilkes, Director at Living Cell Technologies Ltd., holds 52.15M shares in Living Cell Technologies Ltd. (Ticker: LVCLF).
Bradley John Dilkes has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bradley John Dilkes's holdings
Insider Roles
Director
Roles that Bradley John Dilkes holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Bradley John Dilkes
Bradley John Dilkes's Trading History
List of latest transactions for each holding click on a transaction to see Bradley John Dilkes's performance on stock
You May Also Like
Bradley John Dilkes insider profile FAQ
What is the percentage of profitable transactions made by Bradley John Dilkes?
The percentage of profitable transactions made by Bradley John Dilkes is ―.
What is the average return per transaction made by Bradley John Dilkes?
The average return per transaction made by Bradley John Dilkes is ―.
What stocks does Bradley John Dilkes hold?
Bradley John Dilkes holds: LVCLF stocks.
What was Bradley John Dilkes’s latest transaction?
Bradley John Dilkes latest transaction was an Uninformative Buy of ―.
What was Bradley John Dilkes's most profitable transaction?
Bradley John Dilkes’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Bradley John Dilkes's role in Living Cell Technologies Ltd.?
Bradley John Dilkes's role in Living Cell Technologies Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.